Skip links

|Zantac®| At A Glance

Now being referred to as potentially the largest MDL in recent history, cases involving Zantac use are expected to grow. Here’s what you need to know:

What is Zantac? 

Zantac has been on the market since the 1980s – in both prescription and over the counter formulations. Prescription Zantac is used to treat and prevent ulcers and treat gastroesophageal reflux disease. When purchased over the counter it is used to prevent and relieve heartburn and acid indigestion.

The active ingredient in Zantac is ranitidine. When ingested, it is believed that the drug creates NDMA (N-nitrosodimethylamine), a carcinogen first developed for use in making rocket fuel. The allowable limit of NDMA in the human body is 96 NG. Recent studies by Valisure, an online pharmacy, tested the levels of NDMA in 10 volunteers who received 150mg doses of ranitidine. The results showed that the content of NDMA in each volunteer’s urine was greater than 40,000 NG, which indicates that this drug is highly dangerous to the human body. Additionally, it was later discovered that storing ranitidine above room temperature might result in higher  levels of NDMA.

While there are many other similar drugs on the market, no other antacid has tested positive for NDMA.

What are the major injuries? 

Plaintiffs are suing based on Zantac’s failure to warn and false advertising of the harmful drug. Zantac failed to warn consumers of its NDMA content and its connection to multiple types of cancer. A connection has been made between Zantac and the following cancers: stomach, liver, colon, prostate, kidney, lung, and bladder cancer.

Where are the cases? 

Around early February, about 140 cases were consolidated in the Southern District of Florida as MDL 2924. The presiding judge over these cases will be U.S. District Judge Robin Rosenberg.

Who are the potential defendants? 

The defendants include the past and present manufacturers of Zantac: Sanofi US Services Inc., Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., and GlaxoSmithKline.

For the latest developments, please read our blog posts on Zantac.

Learn how Verus can help your firm manage your Roundup cases so you can focus on maximizing the number of clients you can represent. Learn more about our Zantac services.

|CONTACT US|  |REQUEST PROPOSAL|  |888.681.1129|